Globally Trusted Brands

Arteether (alpha-beta) Injection

Available Strength: 75mg, 150mg

Product Details

Revetus Healthcare is India based manufacturer, supplier and exporter of Antimalarial Arteether (alpha-beta) Injection.

Severe malaria, mostly due to Plasmodium falciparum infection, accounts for over one million deaths each year as per WHO. Most people with severe malaria require drugs by injections (intravenous or intramuscular) or given rectally. This is because people with severe malaria have a severe illness such as cerebral malaria (an unrousable coma that cannot be attributed to any other cause other than malaria) or repeated generalized convulsions, which may prevent them from taking oral medication. Alpha-Beta Arteether is used in the treatment of malaria. It is not used to prevent malaria or to treat severe malaria (where it has affected the brain, lungs or kidneys). Alpha-Beta Arteether is an antiparasitic medication.

All products are manufactured at GMP approved facilities with modern infrastructure and analytical capabilities, ensuring better results and safety for patients. Our products are well accepted globally. As a reputed and fast growing independent pharmaceutical company, we offer flexible terms of trade with individual attention to each business associates. We solve the challenges of working with an extended support so as to facilitate a productive & profitable long term business partnerships.

Our business activities include:

  • Exports of wide range of branded and generic tablets, capsules, injections, oral liquids, topical products, sachets, powders, sterile dosage forms, premix for fill-finish projects and other medical products
  • Contract Manufacturing / Third Party Manufacturing
  • New Product Development / Formulation Developments for Pharmaceuticals as per regional guidelines
  • Dossier Development with stability studies, validations, BABE and other requirements

For more information, write to us at exports@revetus.com

All International brands and products are regulated and comply as per country specific guidelines. For product specific detailed contents, ingredients, uses, indications, label claims, mechanism of action, dosage, how to use, side effects and drug interactions, please refer to Patient Information Leaflet (PIL) / Pack Insert (PI), also available in regional languages with product. To report any adverse drug reaction, side effects or any drug interaction, write to us at pv@revetus.com, pharmacovigilance department, mentioning batch number and manufacturing date.